EMEA-001739-PIP02-16-M01
Key facts
Active substance |
|
Therapeutic area |
Pain
|
Decision number |
P/0177/2022
|
PIP number |
EMEA-001739-PIP02-16-M01
|
Pharmaceutical form(s) |
Nasal spray, solution
|
Condition(s) / indication(s) |
Treatment of acute pain
|
Route(s) of administration |
Intranasal use
|
Contact for public enquiries |
Cessatech A/S
E-mail: info@cessatech.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|